$1.45 Billion is the total value of Vivo Capital, LLC's 48 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 20.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SVA | Sinovac Biotech Ltd. | $615,369,410 | 0.0% | 5,900,000 | 0.0% | 42.48% | -0.5% | |
| HRMY | Harmony Biosciences Holdings Inc | $91,713,832 | +7.8% | 2,606,247 | 0.0% | 6.33% | +7.2% | |
| VRNA | Verona Pharma PLCads | $89,843,267 | +5.3% | 4,249,918 | 0.0% | 6.20% | +4.7% | |
| AVDL | Buy | Avadel Pharmaceuticals PLCadr | $63,111,429 | +83.2% | 3,829,577 | +1.8% | 4.36% | +82.2% |
| TERN | Terns Pharmaceuticals Inc | $58,257,430 | -26.1% | 6,657,992 | 0.0% | 4.02% | -26.5% | |
| GERN | Sell | Geron Corp | $53,044,075 | +26.8% | 16,524,634 | -14.3% | 3.66% | +26.1% |
| TARS | Tarsus Pharmaceuticals Inc | $40,877,954 | +43.8% | 2,262,200 | 0.0% | 2.82% | +43.0% | |
| VRDN | Viridian Therapeutics Inc | $39,924,545 | -6.5% | 1,678,207 | 0.0% | 2.76% | -7.0% | |
| VECT | VectivBio Holding AG | $39,362,771 | +98.2% | 2,333,300 | 0.0% | 2.72% | +97.2% | |
| KDNY | Buy | Chinook Therapeutics Inc | $35,918,051 | +77.9% | 934,879 | +7.2% | 2.48% | +76.9% |
| ALXO | ALX Oncology Holdings Inc | $31,692,560 | +66.2% | 4,220,048 | 0.0% | 2.19% | +65.3% | |
| COGT | Buy | Cogent Biosciences Inc | $26,580,101 | +23.5% | 2,244,941 | +12.5% | 1.84% | +22.8% |
| New | Icosavax, Inc. | $16,926,360 | – | 1,704,568 | +100.0% | 1.17% | – | |
| GRCL | Buy | Gracell Biotechnologies Incsponsored ads | $15,123,517 | +455.4% | 3,969,427 | +171.1% | 1.04% | +452.4% |
| Astria Therapeutics Inc | $14,004,388 | -37.4% | 1,681,199 | 0.0% | 0.97% | -37.7% | ||
| Sell | Ventyx Biosciences Inc | $13,844,060 | -31.4% | 422,075 | -29.9% | 0.96% | -31.7% | |
| Buy | Arcellx Inc. | $13,716,282 | +53.1% | 433,785 | +49.2% | 0.95% | +52.3% | |
| ALLK | Sell | Allakos Inc | $13,027,680 | -28.9% | 2,988,000 | -27.5% | 0.90% | -29.3% |
| ZLAB | Buy | Zai Lab Ltd ADRadr | $12,353,854 | -10.9% | 445,505 | +6.9% | 0.85% | -11.3% |
| OLMA | Sell | Olema Pharmaceuticals Inc | $12,093,617 | +106.3% | 1,339,271 | -20.7% | 0.84% | +105.2% |
| New | Verastem Inc | $11,446,150 | – | 1,538,461 | +100.0% | 0.79% | – | |
| CMPX | Compass Therapeutics Inc | $11,308,153 | -2.8% | 3,556,023 | 0.0% | 0.78% | -3.2% | |
| ASLN | Sell | Aslan Pharmaceuticals Ltdads | $10,369,314 | +533.7% | 2,840,908 | -0.0% | 0.72% | +528.1% |
| ALPN | New | Alpine Immune Sciences Inc | $9,405,306 | – | 914,913 | +100.0% | 0.65% | – |
| ACRS | Aclaris Therapeutics, Inc. | $9,318,803 | +28.2% | 898,631 | 0.0% | 0.64% | +27.6% | |
| AMRS | Amyris, Inc | $7,983,353 | -24.3% | 7,750,828 | 0.0% | 0.55% | -24.6% | |
| KALV | KalVista Pharmaceuticals Inc. | $7,704,072 | +14.5% | 856,008 | 0.0% | 0.53% | +13.9% | |
| GTH | Genetron Holdings Ltdads | $7,556,294 | -92.8% | 8,124,174 | 0.0% | 0.52% | -92.8% | |
| TIL | Instil Bio Inc | $6,880,220 | -16.6% | 12,486,787 | 0.0% | 0.48% | -17.1% | |
| DCTH | New | Delcath Systems, Inc. | $6,872,328 | – | 1,178,787 | +100.0% | 0.47% | – |
| DYN | Dyne Therapeutics Inc | $6,498,473 | -2.3% | 577,642 | 0.0% | 0.45% | -2.8% | |
| Aadi Bioscience Inc | $6,456,277 | 0.0% | 509,572 | 0.0% | 0.45% | -0.4% | ||
| Sera Prognostics Inc | $6,115,556 | -14.0% | 1,856,011 | 0.0% | 0.42% | -14.4% | ||
| IO Biotech Inc | $5,895,390 | +4.3% | 3,015,545 | 0.0% | 0.41% | +3.8% | ||
| DBVT | DBV Technologies SAsponsored adr | $5,146,863 | +12.4% | 2,708,875 | 0.0% | 0.36% | +11.6% | |
| BOLT | Bolt Therapeutics Inc | $4,955,252 | -7.9% | 3,871,291 | 0.0% | 0.34% | -8.3% | |
| ARWR | Arrowhead Pharmaceuticals Inc | $4,900,076 | +40.4% | 137,411 | 0.0% | 0.34% | +39.7% | |
| IOVA | Iovance Biotherapeutics Inc | $4,611,601 | +15.2% | 655,057 | 0.0% | 0.32% | +14.4% | |
| CLNN | New | Clene Inc | $3,706,910 | – | 4,520,622 | +100.0% | 0.26% | – |
| IMPL | Impel NeuroPharma Inc | $3,663,682 | -9.3% | 2,884,789 | 0.0% | 0.25% | -9.6% | |
| ALGS | Aligos Therapeutics Inc | $3,444,166 | +11.1% | 3,547,030 | 0.0% | 0.24% | +10.7% | |
| BCAB | BioAtla Inc | $1,911,543 | +11.9% | 637,181 | 0.0% | 0.13% | +11.9% | |
| FULC | Fulcrum Therapeutics Inc | $1,815,000 | +15.8% | 550,000 | 0.0% | 0.12% | +14.7% | |
| IMUX | Immunic Inc | $1,586,782 | +68.5% | 632,184 | 0.0% | 0.11% | +69.2% | |
| CDXS | Codexis, Inc | $1,086,803 | -32.4% | 388,144 | 0.0% | 0.08% | -33.0% | |
| RZLT | Rezolute Inc | $969,157 | +3.1% | 489,473 | 0.0% | 0.07% | +3.1% | |
| FIXX | Homology Medicines, Inc. | $327,510 | -14.1% | 370,068 | 0.0% | 0.02% | -11.5% | |
| DTIL | Precision Biosciences Inc | $73,774 | -30.2% | 140,255 | 0.0% | 0.01% | -28.6% | |
| Exit | Minerva Surgical Inc | $0 | – | -2,215,667 | -100.0% | -0.03% | – | |
| MRUS | Exit | Merus NV | $0 | – | -353,600 | -100.0% | -0.45% | – |
| BLU | Exit | Bellus Health Inc | $0 | – | -1,017,152 | -100.0% | -0.51% | – |
| LEGN | Exit | Legend Biotech Corp Sponsoredsponsored ads | $0 | – | -244,375 | -100.0% | -0.82% | – |
| PCVX | Exit | Vaxcyte Inc | $0 | – | -579,508 | -100.0% | -1.51% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 29 | Q3 2023 | 33.5% |
| CODEXIS INC | 29 | Q3 2023 | 8.0% |
| ASCENDIS PHARMA A/S | 25 | Q3 2022 | 24.0% |
| KALVISTA PHARMACEUTICALS INC | 25 | Q3 2023 | 3.9% |
| Verona Pharma PLC ADR | 24 | Q3 2023 | 7.6% |
| AMYRIS INC | 23 | Q3 2023 | 8.8% |
| EIGER BIOPHARMACEUTICALS INC | 23 | Q1 2022 | 8.7% |
| Zai Lab Ltd ADR | 22 | Q3 2023 | 1.8% |
| Arrowhead Pharmaceuticals Inc | 21 | Q3 2023 | 6.9% |
| HOMOLOGY MEDICINES INC | 21 | Q3 2023 | 3.7% |
View Vivo Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SINOVAC BIOTECH LTDSold out | August 27, 2018 | 0 | 0.0% |
View Vivo Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-22 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Vivo Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.